2-73291865-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001965.4(EGR4):āc.1053C>Gā(p.Phe351Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000253 in 1,580,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001965.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGR4 | NM_001965.4 | c.1053C>G | p.Phe351Leu | missense_variant | 2/2 | ENST00000436467.4 | |
EGR4 | XM_047443603.1 | c.1050C>G | p.Phe350Leu | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGR4 | ENST00000436467.4 | c.1053C>G | p.Phe351Leu | missense_variant | 2/2 | 1 | NM_001965.4 | P2 | |
EGR4 | ENST00000545030.1 | c.1362C>G | p.Phe454Leu | missense_variant | 2/2 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182836Hom.: 0 AF XY: 0.00000985 AC XY: 1AN XY: 101516
GnomAD4 exome AF: 0.00000210 AC: 3AN: 1427886Hom.: 0 Cov.: 31 AF XY: 0.00000282 AC XY: 2AN XY: 708638
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2022 | The c.1362C>G (p.F454L) alteration is located in exon 2 (coding exon 2) of the EGR4 gene. This alteration results from a C to G substitution at nucleotide position 1362, causing the phenylalanine (F) at amino acid position 454 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at